Repair of topoisomerase II-mediated DNA damage: Fixing DNA damage arising from a protein covalently trapped on DNA

DNA Topoisomerases and Cancer

Volumn , Issue , 2012, Pages 381-407

  Nitiss, John L ^a   Soans, Eroica ^b   Berk, Jeffrey ^b   Seth, Aman ^b   Mishina, Margarita ^b   Nitiss, Karin C ^b  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^b ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84902093060     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-1-4614-0323-4_18     Document Type: Chapter

References (108)

1. Adachi, N., Iiizumi, S., So, S., and Koyama, H. (2004). Genetic evidence for involvement of two distinct nonhomologous end-joining pathways in repair of topoisomerase II-mediated DNA damage. Biochem Biophys Res Commun 318, 856-861.
2. Adachi, N., Suzuki, H., Iiizumi, S., and Koyama, H. (2003). Hypersensitivity of nonhomologous DNA end-joining mutants to VP-16 and ICRF-193: implications for the repair of topoisomerase II-mediated DNA damage. J Biol Chem 278, 35897-35902.
3. Ajimura, M., Leem, S.H., and Ogawa, H. (1993). Identification of new genes required for meiotic recombination in Saccharomyces cerevisiae. Genetics 133, 51-66.
4. Andersen, A.H., Christiansen, K., Zechiedrich, E.L., Jensen, P.S., Osheroff, N., and Westergaard, O. (1989). Strand specificity of the topoisomerase II mediated double-stranded DNA cleavage reaction. Biochemistry 28, 6237-6244.
5. Baldwin, E.L., Berger, A.C., Corbett, A.H., and Osheroff, N. (2005). Mms22p protects Saccharomyces cerevisiae from DNA damage induced by topoisomerase II. Nucleic Acids Res 33, 1021-1030.
6. Baldwin, E.L., and Osheroff, N. (2005). Etoposide, topoisomerase II and cancer. Curr Med Chem Anticancer Agents 5, 363-372.
7. Banerjee, S., Kaye, S.B., and Ashworth, A. (2010). Making the best of PARP inhibitors in ovarian cancer. Nat Rev Clin Oncol 7, 508-519.
8. Barthelmes, H.U., Habermeyer, M., Christensen, M.O., Mielke, C., Interthal, H., Pouliot, J.J., Boege, F., and Marko, D. (2004). TDP1 overexpression in human cells counteracts DNA damage mediated by topoisomerases I and II. J Biol Chem 279, 55618-55625.
9. Bennett, C.B., Lewis, L.K., Karthikeyan, G., Lobachev, K.S., Jin, Y.H., Sterling, J.F., Snipe, J.R., and Resnick, M.A. (2001). Genes required for ionizing radiation resistance in yeast. Nat Genet 29, 426-434.
10. Bergerat, A., de Massy, B., Gadelle, D., Varoutas, P.C., Nicolas, A., and Forterre, P. (1997). An atypical topoisomerase II from Archaea with implications for meiotic recombination. Nature 386, 414-417.
11. Bhaskara, V., Dupre, A., Lengsfeld, B., Hopkins, B.B., Chan, A., Lee, J.H., Zhang, X., Gautier, J., Zakian, V., and Paull, T.T. (2007). Rad50 adenylate kinase activity regulates DNA tethering by Mre11/Rad50 complexes. Mol Cell 25, 647-661.
12. Bjornsti, M.A. (2002). Cancer therapeutics in yeast. Cancer Cell 2, 267-273.
13. Borde, V. (2007). The multiple roles of the Mre11 complex for meiotic recombination. Chromosome Res 15, 551-563.
14. Cao, L., Alani, E., and Kleckner, N. (1990). A pathway for generation and processing of double-strand breaks during meiotic recombination in S. cerevisiae. Cell 61, 1089-1101.
15. Chang, M., Bellaoui, M., Boone, C., and Brown, G.W. (2002). A genome-wide screen for methyl methanesulfonate-sensitive mutants reveals genes required for S phase progression in the presence of DNA damage. Proc Natl Acad Sci USA 99, 16934-16939.
16. Choi, H.J., Cho, B.C., Shin, S.J., Cheon, S.H., Jung, J.Y., Chang, J., Kim, S.K., Sohn, J.H., and Kim, J.H. (2008). Combination of topotecan and etoposide as a salvage treatment for patients with recurrent small cell lung cancer following irinotecan and platinum first-line chemotherapy. Cancer Chemotherapy and Pharmacology 61, 309-313.
17. Cortes Ledesma, F., El Khamisy, S.F., Zuma, M.C., Osborn, K., and Caldecott, K.W. (2009). A human 5c-tyrosyl DNA phosphodiesterase that repairs topoisomerase-mediated DNA damage. Nature 461, 674-678.
18. Critchlow, S.E., and Jackson, S.P. (1998). DNA end-joining: from yeast to man. Trends Biochem Sci 23, 394-398.
19. D'Arpa, P., Beardmore, C., and Liu, L.F. (1990). Involvement of nucleic acid synthesis in cell killing mechanisms of topoisomerase poisons. Cancer Res 50, 6919-6924.
20. Deng, C., Brown, J.A., You, D., and Brown, J.M. (2005). Multiple endonucleases function to repair covalent topoisomerase I complexes in Saccharomyces cerevisiae. Genetics 170, 591-600.
21. Dexheimer, T.S., Stephen, A.G., Fivash, M.J., Fisher, R.J., and Pommier, Y. (2010). The DNA binding and 3c-end preferential activity of human tyrosyl-DNA phosphodiesterase. Nucleic Acids Res 38, 2444-2452.
22. Dombernowsky, P., Gehl, J., Boesgaard, M., Paaske, T., and Jensen, B.V. (1996). Doxorubicin and paclitaxel, a highly active combination in the treatment of metastatic breast cancer. Seminars in Oncology 23, 23-27.
23. Downes, C.S., Clarke, D.J., Mullinger, A.M., Gimenez-Abian, J.F., Creighton, A.M., and Johnson, R.T. (1994). A topoisomerase II-dependent G2 cycle checkpoint in mammalian cells/ [published erratum appears in Nature 1994 Dec 15;372(6507):710]. Nature 372, 467-470.
24. Fan, J.R., Peng, A.L., Chen, H.C., Lo, S.C., Huang, T.H., and Li, T.K. (2008). Cellular processing pathways contribute to the activation of etoposide-induced DNA damage responses. DNA Repair 7, 452-463.
25. Fekairi, S., Scaglione, S., Chahwan, C., Taylor, E.R., Tissier, A., Coulon, S., Dong, M.Q., Ruse, C., Yates, J.R., 3rd, Russell, P., et al. (2009). Human SLX4 is a Holliday junction resolvase subunit that binds multiple DNA repair/recombination endonucleases. Cell 138, 78-89.
26. Felix, C.A., Kolaris, C.P., and Osheroff, N. (2006). Topoisomerase II and the etiology of chromosomal translocations. DNA Repair (Amst) 5, 1093-1108.
27. Fricke, W.M., and Brill, S.J. (2003). Slx1-Slx4 is a second structure-specific endonuclease functionally redundant with Sgs1-Top3. Genes Dev 17, 1768-1778.
28. Froelich-Ammon, S.J., Patchan, M.W., Osheroff, N., and Thompson, R.B. (1995). Topoisomerase II binds to ellipticine in the absence or presence of DNA. Characterization of enzyme-drug interactions by fluorescence spectroscopy. J Biol Chem 270, 14998-15004.
29. Habraken, Y., Sung, P., Prakash, L., and Prakash, S. (1994). A conserved 5c to 3c exonuclease activity in the yeast and human nucleotide excision repair proteins RAD2 and XPG. J Biol Chem 269, 31342-31345.
30. Hamilton, N.K., and Maizels, N. (2010). MRE11 function in response to topoisomerase poisons is independent of its function in double-strand break repair in Saccharomyces cerevisiae. PLoS One 5, e15387.
31. Hanawalt, P.C., and Spivak, G. (2008). Transcription-coupled DNA repair: two decades of progress and surprises. Nat Rev Mol Cell Biol 9, 958-970.
32. Hartsuiker, E., Neale, M.J., and Carr, A.M. (2009). Distinct requirements for the Rad32(Mre11) nuclease and Ctp1(CtIP) in the removal of covalently bound topoisomerase I and II from DNA. Mol Cell 33, 117-123.
33. Holm, C., Covey, J.M., Kerrigan, D., and Pommier, Y. (1989). Differential requirement of DNA replication for the cytotoxicity of DNA topoisomerase I and II inhibitors in Chinese hamster DC3F cells. Cancer Res 49, 6365-6368.
34. Hopfner, K.P., and Tainer, J.A. (2003). Rad50/SMC proteins and ABC transporters: unifying concepts from high-resolution structures. Curr Opin Struct Biol 13, 249-255.
35. Howard, M.T., Neece, S.H., Matson, S.W., and Kreuzer, K.N. (1994). Disruption of a topoisomerase-DNA cleavage complex by a DNA helicase. Proc Natl Acad Sci USA 91, 12031-12035.
36. Huang, X., Traganos, F., and Darzynkiewicz, Z. (2003). DNA damage induced by DNA topoisomerase I- and topoisomerase II-inhibitors detected by histone H2AX phosphorylation in relation to the cell cycle phase and apoptosis. Cell Cycle 2, 614-619.
37. Injac, R., and Strukej, B. (2008). Recent Advances in Protection Against Doxorubicin-induced Toxicity. Technology in Cancer Research & Treatment 7, 497-516.
38. Interthal, H., Chen, H.J., Kehl-Fie, T.E., Zotzmann, J., Leppard, J.B., and Champoux, J.J. (2005). SCAN1 mutant Tdp1 accumulates the enzyme--DNA intermediate and causes camptothecin hypersensitivity. EMBO J 24, 2224-2233.
39. Jin, S., Inoue, S., and Weaver, D.T. (1998). Differential etoposide sensitivity of cells deficient in the Ku and DNA-PKcs components of the DNA-dependent protein kinase. Carcinogenesis 19, 965-971.
40. Kantidze, O.L., and Razin, S.V. (2007). Chemotherapy-related secondary leukemias: A role for DNA repair by error-prone non-homologous end joining in topoisomerase II - Induced chromosomal rearrangements. Gene 391, 76-79.
41. Keeney, S., Giroux, C.N., and Kleckner, N. (1997). Meiosis-specific DNA double-strand breaks are catalyzed by Spo11, a member of a widely conserved protein family. Cell 88, 375-384.
42. Keeney, S., and Kleckner, N. (1995). Covalent protein-DNA complexes at the 5c strand termini of meiosis-specific double-strand breaks in yeast. Proc Natl Acad Sci USA 92, 11274-11278.
43. Keeney, S., and Neale, M.J. (2006). Initiation of meiotic recombination by formation of DNA double-strand breaks: mechanism and regulation. Biochem Soc Trans 34, 523-525.
44. Kingma, P.S., and Osheroff, N. (1997). Apurinic sites are position-specific topoisomerase II poisons. J Biol Chem 272, 1148-1155.
45. Kurosawa, A., Koyama, H., Takayama, S., Miki, K., Ayusawa, D., Fujii, M., Iiizumi, S., and Adachi, N. (2008). The requirement of Artemis in double-strand break repair depends on the type of DNA damage. DNA Cell Biol 27, 55-61.
46. Lengsfeld, B.M., Rattray, A.J., Bhaskara, V., Ghirlando, R., and Paull, T.T. (2007). Sae2 is an endonuclease that processes hairpin DNA cooperatively with the Mre11/Rad50/Xrs2 complex. Mol Cell 28, 638-651.
47. Lewis, L.K., Kirchner, J.M., and Resnick, M.A. (1998). Requirement for end-joining and checkpoint functions, but not RAD52-mediated recombination, after EcoRI endonuclease cleavage of Saccharomyces cerevisiae DNA. Mol Cell Biol 18, 1891-1902.
48. Lewis, L.K., and Resnick, M.A. (2000). Tying up loose ends: nonhomologous end-joining in Saccharomyces cerevisiae. Mutat Res 451, 71-89.
49. Lieber, M. (2010). The mechanism of double-strand DNA break repair by the nonhomologous DNA end-joining pathway. Annu Rev Biochem 79, 181-211.
50. Lieu, C., Chow, L., Pierson, A., Eckhardt, S., O'Bryant, C., Morrow, M., Tran, Z., Wright, J., and Gore, L. (2009). A phase I study of bortezomib, etoposide and carboplatin in patients with advanced solid tumors refractory to standard therapy. Investigational New Drugs 27, 53-62.
51. Liu, J., Wu, T.C., and Lichten, M. (1995). The location and structure of double-strand DNA breaks induced during yeast meiosis: evidence for a covalently linked DNA-protein intermediate. EMBO J 14, 4599-4608.
52. Malik, M., Nitiss, K.C., Enriquez-Rios, V., and Nitiss, J.L. (2006). Roles of nonhomologous end-joining pathways in surviving topoisomerase II-mediated DNA damage. Mol Cancer Ther 5, 1405-1414.
53. Manfrini, N., Guerini, I., Citterio, A., Lucchini, G., and Longhese, M.P. (2010). Processing of meiotic DNA double strand breaks requires cyclin-dependent kinase and multiple nucleases. J Biol Chem 285, 11628-11637.
54. Mao, Y., Desai, S.D., Ting, C.Y., Hwang, J., and Liu, L.F. (2001). 26S proteasome-mediated degradation of topoisomerase II cleavable complexes. J Biol Chem 276, 40652-40658.
55. Marians, K.J., and Hiasa, H. (1997). Mechanism of quinolone action. A drug-induced structural perturbation of the DNA precedes strand cleavage by topoisomerase IV. J Biol Chem 272, 9401-9409.
56. Markovits, J., Pommier, Y., Kerrigan, D., Covey, J.M., Tilchen, E.J., and Kohn, K.W. (1987). Topoisomerase II-mediated DNA breaks and cytotoxicity in relation to cell proliferation and the cell cycle in NIH 3T3 fibroblasts and L1210 leukemia cells. Cancer Res 47, 2050-2055.
57. Michel, B., Grompone, G., Flores, M.J., and Bidnenko, V. (2004). Multiple pathways process stalled replication forks. Proc Natl Acad Sci USA 101, 12783-12788.
58. Milman, N., Higuchi, E., and Smith, G.R. (2009). Meiotic DNA double-strand break repair requires two nucleases, MRN and Ctp1, to produce a single size class of Rec12 (Spo11)-oligonucleotide complexes. Mol Cell Biol 29, 5998-6005.
59. Mistry, A.R., Felix, C.A., Whitmarsh, R.J., Mason, A., Reiter, A., Cassinat, B., Parry, A., Walz, C., Wiemels, J.L., Segal, M.R., et al. (2005). DNA topoisomerase II in therapy-related acute promyelocytic leukemia. N Engl J Med 352, 1529-1538.
60. Moreau, S., Ferguson, J.R., and Symington, L.S. (1999). The nuclease activity of Mre11 is required for meiosis but not for mating type switching, end joining, or telomere maintenance. Mol Cell Biol 19, 556-566.
61. Munoz, I.M., Hain, K., Declais, A.C., Gardiner, M., Toh, G.W., Sanchez-Pulido, L., Heuckmann, J.M., Toth, R., Macartney, T., Eppink, B., et al. (2009). Coordination of structure-specific nucleases by human SLX4/BTBD12 is required for DNA repair. Mol Cell 35, 116-127.
62. Nakamura, K., Kogame, T., Oshiumi, H., Shinohara, A., Sumitomo, Y., Agama, K., Pommier, Y., Tsutsui, K.M., Tsutsui, K., Hartsuiker, E., et al. (2010). Collaborative action of Brca1 and CtIP in elimination of covalent modifications from double-strand breaks to facilitate subsequent break repair. PLoS Genet 6, e1000828.
63. Neale, M.J., Pan, J., and Keeney, S. (2005). Endonucleolytic processing of covalent protein-linked DNA double-strand breaks. Nature 436, 1053-1057.
64. Nitiss, J., and Wang, J.C. (1988). DNA topoisomerase-targeting antitumor drugs can be studied in yeast. Proc Natl Acad Sci USA 85, 7501-7505.
65. Nitiss, J.L. (1994). Yeast as a genetic model system for studying topoisomerase inhibitors. Advances in Pharmacology 29B, 201-226.
66. Nitiss, J.L. (2009). DNA topoisomerase II and its growing repertoire of biological functions. Nat Rev Cancer 9, 327-337.
67. Nitiss, J.L., and Beck, W.T. (1996). Antitopoisomerase drug action and resistance. Eur J Cancer 32A, 958-966.
68. Nitiss, J.L., Liu, Y.X., Harbury, P., Jannatipour, M., Wasserman, R., and Wang, J.C. (1992). Amsacrine and etoposide hypersensitivity of yeast cells overexpressing DNA topoisomerase II. Cancer Res 52, 4467-4472.
69. Nitiss, J.L., Liu, Y.X., and Hsiung, Y. (1993). A temperature sensitive topoisomerase II allele confers temperature dependent drug resistance on amsacrine and etoposide: a genetic system for determining the targets of topoisomerase II inhibitors. Cancer Res 53, 89-93.
70. Nitiss, J.L., Nitiss, K.C., Rose, A., and Waltman, J.L. (2001). Overexpression of type I topoisomerases sensitizes yeast cells to DNA damage. J Biol Chem 276, 26708-26714.
71. Nitiss, J.L., Rose, A., Sykes, K.C., Harris, J., and Zhou, J. (1996). Using yeast to understand drugs that target topoisomerases. Ann NY Acad Sci 803, 32-43.
72. Nitiss, J.L., and Wang, J.C. (1996). Mechanisms of cell killing by drugs that trap covalent complexes between DNA topoisomerases and DNA. Mol Pharmacol 50, 1095-1102.
73. Nitiss, K.C., Malik, M., He, X., White, S.W., and Nitiss, J.L. (2006). Tyrosyl-DNA phosphodiesterase (Tdp1) participates in the repair of Top2-mediated DNA damage. Proc Natl Acad Sci USA 103, 8953-8958.
74. Pommier, Y., Laco, G.S., Kohlhagen, G., Sayer, J.M., Kroth, H., and Jerina, D.M. (2000). Position-specific trapping of topoisomerase I-DNA cleavage complexes by intercalated benzo[a]- pyrene diol epoxide adducts at the 6-amino group of adenine. Proc Natl Acad Sci USA 97, 10739-10744.
75. Pommier, Y., Minford, J.K., Schwartz, R.E., Zwelling, L.A., and Kohn, K.W. (1985). Effects of the DNA intercalators 4c-(9-acridinylamino)methanesulfon-manisidide and 2-methyl-9-hydroxyel-lipticinium on topoisomerase II mediated DNA strand cleavage and strand passage. Biochemistry 24, 6410-6416.
76. Pouliot, J.J., Yao, K.C., Robertson, C.A., and Nash, H.A. (1999). Yeast gene for a Tyr-DNA phosphodiesterase that repairs topoisomerase I complexes. Science 286, 552-555.
77. Powell, S.N., and Kachnic, L.A. (2008). Therapeutic exploitation of tumor cell defects in homologous recombination. Anticancer Agents Med Chem 8, 448-460.
78. Prakash, S., and Prakash, L. (2000). Nucleotide excision repair in yeast. Mutat Res 451, 13-24.
79. Prinz, S., Amon, A., and Klein, F. (1997). Isolation of COM1, a new gene required to complete meiotic double-strand break-induced recombination in Saccharomyces cerevisiae. Genetics 146, 781-795.
80. Pype, S., Declercq, W., Ibrahimi, A., Michiels, C., Van Rietschoten, J.G., Dewulf, N., de Boer, M., Vandenabeele, P., Huylebroeck, D., and Remacle, J.E. (2000). TTRAP, a novel protein that associates with CD40, tumor necrosis factor (TNF) receptor-75 and TNF receptor-associated factors (TRAFs), and that inhibits nuclear factor-kappa B activation. J Biol Chem 275, 18586-18593.
81. Rehman, F.L., Lord, C.J., and Ashworth, A. (2010). Synthetic lethal approaches to breast cancer therapy. Nat Rev Clin Oncol 7, 718-724.
82. Robinson, M.J., Martin, B.A., Gootz, T.D., McGuirk, P.R., Moynihan, M., Sutcliffe, J.A., and Osheroff, N. (1991). Effects of quinolone derivatives on eukaryotic topoisomerase II. A novel mechanism for enhancement of enzyme-mediated DNA cleavage. J Biol Chem 266, 14585-14592.
83. Robinson, M.J., and Osheroff, N. (1990). Stabilization of the topoisomerase II-DNA cleavage complex by antineoplastic drugs: inhibition of enzyme-mediated DNA religation by 4c-(9-acrid-inylamino)methanesulfon-m-anisidide. Biochemistry 29, 2511-2515.
84. Rogojina, A.T., and Nitiss, J.L. (2008). Isolation and Characterization of mAMSA-hypersensitive Mutants CYTOTOXICITY OF Top2 COVALENT COMPLEXES CONTAINING DNA SINGLE STRAND BREAKS. Journal of Biological Chemistry 283, 29239-29250.
85. Rothstein, R., Michel, B., and Gangloff, S. (2000). Replication fork pausing and recombination or "gimme a break". Genes Dev 14, 1-10.
86. Sabourin, M., Nitiss, J.L., Nitiss, K.C., Tatebayashi, K., Ikeda, H., and Osheroff, N. (2003). Yeast recombination pathways triggered by topoisomerase II-mediated DNA breaks. Nucleic Acids Res 31, 4373-4384.
87. Sartori, A.A., Lukas, C., Coates, J., Mistrik, M., Fu, S., Bartek, J., Baer, R., Lukas, J., and Jackson, S.P. (2007). Human CtIP promotes DNA end resection. Nature 450, 509-514.
88. Schoeffler, A.J., and Berger, J.M. (2008). DNA topoisomerases: harnessing and constraining energy to govern chromosome topology. Q Rev Biophys 41, 41-101.
89. Schonn, I., Hennesen, J., and Dartsch, D.C. (2010). Ku70 and Rad51 vary in their importance for the repair of doxorubicin-versus etoposide-induced DNA damage. Apoptosis.
90. Stepanov, A., Nitiss, K.C., Neale, G., and Nitiss, J.L. (2008). Enhancing drug accumulation in S. cerevisiae by repression of pleiotropic drug resistance genes with chimeric transcription repressors. Mol Pharmacol.
91. Svejstrup, J.Q. (2003). Rescue of arrested RNA polymerase II complexes. J Cell Sci 116, 447-451.
92. Svendsen, J.M., Smogorzewska, A., Sowa, M.E., O'Connell, B.C., Gygi, S.P., Elledge, S.J., and Harper, J.W. (2009). Mammalian BTBD12/SLX4 assembles a Holliday junction resolvase and is required for DNA repair. Cell 138, 63-77.
93. Tewey, K.M., Chen, G.L., Nelson, E.M., and Liu, L.F. (1984). Intercalative antitumor drugs interfere with the breakage-reunion reaction of mammalian DNA topoisomerase II. J Biol Chem 259, 9182-9187.
94. Treszezamsky, A.D., Kachnic, L.A., Feng, Z., Zhang, J., Tokadjian, C., and Powell, S.N. (2007). BRCA1- and BRCA2-deficient cells are sensitive to etoposide-induced DNA double-strand breaks via topoisomerase II. Cancer Res 67, 7078-7081.
95. Vance, J.R., and Wilson, T.E. (2002). Yeast Tdp1 and Rad1-Rad10 function as redundant pathways for repairing Top1 replicative damage. Proc Natl Acad Sci USA 99, 13669-13674.
96. Verborg, W.A., Campbell, L.R., Highley, M.S., and Rankin, E.M. (2008). Weekly cisplatin with oral etoposide: a well-tolerated and highly effective regimen in relapsed ovarian cancer. International Journal of Gynecological Cancer 18, 228-234.
97. Walker, J.V., and Nitiss, J.L. (2002). DNA topoisomerase II as a target for cancer chemotherapy. Cancer Invest 20, 570-589.
98. Wang, J.C. (1998). Moving one DNA double helix through another by a type II DNA topoisomerase: the story of a simple molecular machine. Q Rev Biophys 31, 107-144.
99. Westmoreland, T.J., Wickramasekara, S.M., Guo, A.Y., Selim, A.L., Winsor, T.S., Greenleaf, A.L., Blackwell, K.L., Olson, J.A., Jr., Marks, J.R., and Bennett, C.B. (2009). Comparative genome-wide screening identifies a conserved doxorubicin repair network that is diploid specific in Saccharomyces cerevisiae. PLoS One 4, e5830.
100. Williams, R.S., and Tainer, J.A. (2007). Learning our ABCs: Rad50 directs MRN repair functions via adenylate kinase activity from the conserved ATP binding cassette. Mol Cell 25, 789-791.
101. Winzeler, E.A., Shoemaker, D.D., Astromoff, A., Liang, H., Anderson, K., Andre, B., Bangham, R., Benito, R., Boeke, J.D., Bussey, H., et al. (1999). Functional characterization of the S. cerevisiae genome by gene deletion and parallel analysis. Science 285, 901-906.
102. Woudstra, E.C., Gilbert, C., Fellows, J., Jansen, L., Brouwer, J., Erdjument-Bromage, H., Tempst, P., and Svejstrup, J.Q. (2002). A Rad26-Def1 complex coordinates repair and RNA pol II proteolysis in response to DNA damage. Nature 415, 929-933.
103. Yamaguchi-Iwai, Y., Sonoda, E., Sasaki, M.S., Morrison, C., Haraguchi, T., Hiraoka, Y., Yamashita, Y.M., Yagi, T., Takata, M., Price, C., et al. (1999). Mre11 is essential for the maintenance of chromosomal DNA in vertebrate cells. EMBO J 18, 6619-6629.
104. Yang, S.W., Burgin, A.B., Jr., Huizenga, B.N., Robertson, C.A., Yao, K.C., and Nash, H.A. (1996). A eukaryotic enzyme that can disjoin dead-end covalent complexes between DNA and type I topoisomerases. Proc Natl Acad Sci USA 93, 11534-11539.
105. You, Z., and Bailis, J.M. (2010). DNA damage and decisions: CtIP coordinates DNA repair and cell cycle checkpoints. Trends Cell Biol 20, 402-409.
106. Zeng, Z., Cortes-Ledesma, F., El-Khamisy, S.F., and Caldecott, K.W. (2010). TDP2/TTRAP is the major 5c-tyrosyl DNA phosphodiesterase activity in vertebrate cells and is critical for cellular resistance to topoisomerase II-induced DNA damage. J Biol Chem.
107. Zhang, A.L., Lyu, Y.L., Lin, C.P., Zhou, N., Azarova, A.M., Wood, L.M., and Liu, L.F. (2006). A protease pathway for the repair of topoisomerase II-DNA covalent complexes. Journal of Biological Chemistry 281, 35997-36003.
108. Zhang, H., D'Arpa, P., and Liu, L.F. (1990). A model for tumor cell killing by topoisomerase poisons. Cancer Cells 2, 23-27.